rev-RRE inhibitors (NascaCell)

N/A

Report date: 2025/03/19 20:00:56
NME

Base Information

Drug Namerev-RRE inhibitors (NascaCell)
Drug Alias Nameanti-infectives (Nascacell)intramer technology (NascaCell)aptazyme technology (Nascacell)
ClassificationSmall molecules > Nucleosides and nucleotide derivtives > Oligonucleotide > Oligonucleotide aptamer
Mechanisms of ActionHIV replication inhibitors
TargetsUpdating
Therapy Area/IndicationsHIV Infections
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusDiscontinued
Highest Status in ChinaN/A
Originator CompaniesNascaCell GmbH
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNascaCell GmbH
Active IndicationsN/A
Inactive IndicationsHIV Infections

Other Information

ATC CodeN/A
Related LinksN/A